Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Assessment of The Impact of Compliance with Recommendations to Avoid Active Tuberculosis in Patients Treated With TNF Antagonist. (Póster).

02/01/2008

Carmona L, Gómez-Reino J, Descalzo MA, BIOBADASER Study Group.

2006 Annual Scientific Meeting of the American College of Rheumatology. Washington D.C., 10-15 noviembre 2006.